Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender
© Venkatesan et al; licensee BioMed Central Ltd. 2011
Published: 14 September 2011
Neonatal Lupus Erythematodus (NLE) is a rare disease occurring in offspring from mothers with anti-Ro with or without anti-La antibodies. Much is known about the individual manifestations (congenital heart block (CHB), cutaneous rash, hematologic and hepatic laboratory abnormalities and macrocephaly) but it is unclear how these and other autoantibodies (anti-dsDNA, anti-RNP and anti-Sm antibodies) influence disease phenotype.
To analyze the frequency and characteristics of clinical phenotypes seen in NLE and relate these phenotypes to the quality and quantity of autoantibodies.
A cohort of 261 infants whose mothers had anti-Ro antibodies was followed prospectively at The Hospital for Sick Children. All infants underwent the first full clinical evaluation and laboratory testing between 4-12 weeks after birth.
A small majority of infants (150/261, 57%) had one or more NLE manifestations consisting of 56 (37%) with a cutaneous rash, 44 (29%) had liver function abnormalities, 42 (28%) had CHB, 41 (27%) had neutropenia (<1.0x109/l), 21 (14%) had macrocephaly and 9 (6%) had thrombocytopenia. CHB was an isolated finding in more than half of the cases (26/42), as was neutropenia (23/41); the other NLE manifestations most often presented in combination. Where the cohort of NLE patients had slightly more females (59% versus 41% males), a larger majority of patients with CHB were females (74%), but macrocephaly was seen more in males (62%). The chance of developing NLE was associated with increasing levels of anti-Ro antibodies. Macrocephaly was only seen in infants that still had a positive anti-Ro titer when sampled after birth. Increasing levels of anti-La antibodies were associated primarily with cutaneous rash. Anti-dsDNA, anti-RNP and anti-Sm antibodies were present in less than 5% of infants and could not be related to clinical phenotype.
In this large cohort of prospectively followed infants from mothers with anti-Ro antibodies, a majority developed NLE. The clinical phenotype of NLE appeared to be related to gender and to the quantity of anti-Ro and -La antibodies.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.